| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/28/1998 | CA2013050C Transdermal therapeutic system exhibiting an increased active substance flow and process for the production thereof |
| 04/28/1998 | CA2010225C Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances (1) |
| 04/28/1998 | CA2010218C Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances |
| 04/23/1998 | WO1998016553A1 Bordetella strain expressing the fha hybrid, liposomes and vaccines |
| 04/23/1998 | WO1998016252A1 New pharmaceutical parenteral formulation of a thrombin inhibitor |
| 04/23/1998 | WO1998016250A1 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 04/23/1998 | WO1998016246A1 Cytokine enhanced immunotherapy for brain tumors |
| 04/23/1998 | WO1998016240A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 04/23/1998 | WO1998016237A1 Anion exchange resin-containing tablets |
| 04/23/1998 | WO1998016229A1 Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
| 04/23/1998 | WO1998016213A1 Use of sodium 2-mercaptoethanesulfonate in surgery |
| 04/23/1998 | WO1998016210A1 Fluorocarbon-containing agents for pulmonary lavage and drug delivery |
| 04/23/1998 | WO1998016209A2 Bioceramic compositions |
| 04/23/1998 | WO1998016208A1 Methods and apparatus for treatment of parkinson's disease |
| 04/23/1998 | WO1998016207A1 Micro-capsule support material |
| 04/23/1998 | WO1998016206A1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| 04/23/1998 | WO1998016205A2 Stable glassy state powder formulations |
| 04/23/1998 | WO1998016204A1 Process for the manufacture of a pulverous preparation |
| 04/23/1998 | WO1998016203A1 Stabilized gas-supersaturated emulsions and suspensions |
| 04/23/1998 | WO1998016202A2 Fusogenic liposome composition and method |
| 04/23/1998 | WO1998016201A1 Therapeutic liposome composition and method |
| 04/23/1998 | WO1998016200A1 Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof |
| 04/23/1998 | WO1998016199A1 N-acyl phosphatidylethanolamine-mediated liposomal drug delivery |
| 04/23/1998 | WO1998016198A1 Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof |
| 04/23/1998 | WO1998016197A1 Surgical method and composition therefor |
| 04/23/1998 | WO1998016195A1 Pharmaceutical formulation |
| 04/23/1998 | WO1998016191A1 CELLULOSE BINDING DOMAINS (CBDs) FOR ORAL CARE PRODUCTS |
| 04/23/1998 | WO1998016111A1 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 04/23/1998 | WO1998007429A3 Antifungal composition with enhanced bioavailability |
| 04/23/1998 | WO1998005308A3 Terazosin capsules |
| 04/23/1998 | WO1997047323A3 Chitosan drug delivery system |
| 04/23/1998 | CA2505445A1 Fusogenic liposome composition and method |
| 04/23/1998 | CA2270144A1 Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof |
| 04/23/1998 | CA2268841A1 Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof |
| 04/23/1998 | CA2268405A1 Stabilized gas-supersaturated emulsions and suspensions |
| 04/23/1998 | CA2267977A1 Cytokine enhanced immunotherapy for brain tumors |
| 04/23/1998 | CA2240402A1 Anion exchange resin-containing tablets |
| 04/22/1998 | EP0837072A2 Lys (B28) insulins. Human insulin analogues |
| 04/22/1998 | EP0836852A1 Use of amlexanox for the manufacture of a medicament for treating aphtous ulcers |
| 04/22/1998 | EP0836849A2 Pharmaceutical formulations containing gamma amino butyric acid, an anti-oxidant, folic acid, nicotinamide and a lithium salt |
| 04/22/1998 | EP0836645A1 Dry powder formulations of polynucleotide complexes |
| 04/22/1998 | EP0836538A1 Process for producing active substances from unused or discarded devices for the transdermal administration of active substances and/or from their production waste |
| 04/22/1998 | EP0836511A1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 04/22/1998 | EP0836506A1 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| 04/22/1998 | EP0836495A1 Delivery of oxygen-supersaturated physiologic solutions |
| 04/22/1998 | EP0836475A1 Controlled release formulations for poorly soluble drugs |
| 04/22/1998 | EP0836473A1 Ring-shaped devices |
| 04/22/1998 | EP0836472A1 Therapeutic effervescent compositions |
| 04/22/1998 | EP0836453A1 Vascularized tissue regeneration matrices formed by solid free-form fabrication methods |
| 04/22/1998 | EP0836380A1 Fgf9 as a specific ligand for fgfr3 |
| 04/22/1998 | EP0746294A4 Absorption enhancers for topical pharmaceutical formulations |
| 04/22/1998 | EP0725664A4 Disposable dosage unit for iontophoresis-facilitated delivery |
| 04/22/1998 | EP0725633A4 Detection of h. pylori in the stomach |
| 04/22/1998 | EP0515460B1 Docosahexaenoic acid, methods for its production and compounds containing the same |
| 04/22/1998 | CN1179725A Modulation of cell proliferation and wound healing |
| 04/22/1998 | CN1179723A Mucosal preparation containing physiologically active peptide |
| 04/22/1998 | CN1179721A Novel pharmacetical formulation |
| 04/22/1998 | CN1179720A Corticosteroid-containing pharmaceutical compositions |
| 04/22/1998 | CN1179719A Azathioprine compositions for colonic administration |
| 04/22/1998 | CN1179718A Novel pharmaceutical composition |
| 04/22/1998 | CN1179717A Novel pharmaceutical composition |
| 04/22/1998 | CN1179715A Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections |
| 04/22/1998 | CN1179714A Treating urinary incontinence using (s)-oxybutynin and (s) -desethyloxybutynin |
| 04/22/1998 | CN1179712A Medicine feeding system containing angiotensin converting enzyme (ACE) inhibitors |
| 04/22/1998 | CN1179698A Micella nanoparticles |
| 04/22/1998 | CN1179324A Specific pure herbal medicine narcotic oral liquid |
| 04/22/1998 | CN1179319A Granular Chinese medicine composition for child's health |
| 04/22/1998 | CN1179307A Liquid antiacid compositions |
| 04/22/1998 | CN1038106C Method for producing acupuncture point plaster for treatment of cough |
| 04/22/1998 | CN1038105C Method for making apoplexy plaster |
| 04/21/1998 | US5741891 Pulmonary surfactant peptide solubilization process |
| 04/21/1998 | US5741822 Mixed lipid-bicarbonate colloidal particles for delivering drugs |
| 04/21/1998 | US5741810 Prostaglandins for ocular hypotension for treatment of glaucoma |
| 04/21/1998 | US5741806 Suppository compositions containing ondasetron dihydrate |
| 04/21/1998 | US5741805 Controlled release pilocarpine delivery system |
| 04/21/1998 | US5741680 Buffer composition base and method of formulation for oral vaccine delivery |
| 04/21/1998 | US5741600 Absorbable coating and blend |
| 04/21/1998 | US5741525 Vaginal pharmaceutical hydrogen peroxide composition |
| 04/21/1998 | US5741524 Sustained-release formulations utilizing pharmaceutical excipient having improved compressibility |
| 04/21/1998 | US5741523 Stabilized prostaglandin E1 |
| 04/21/1998 | US5741519 The production of active substance compositions in the form of a solid solution of the active substance in a polymer matrix, and active substance compositions produced by this process |
| 04/21/1998 | US5741517 Water-containing liposome system |
| 04/21/1998 | US5741516 Liposomal formulations having extended circulation time in vivo and increased drug retention comprised of sphingomyelin and cholesterol; acidic intraliposomal ph |
| 04/21/1998 | US5741515 Reaction product of phosphates and ketoprofen |
| 04/21/1998 | US5741514 Intravenously injecting small unilammellar lipopsomes of phosphatidylcholines |
| 04/21/1998 | US5741512 Pharmaceutical compositions comprising cyclosporins |
| 04/21/1998 | US5741511 Transdermal drug delivery device for treating erectile dysfunction |
| 04/21/1998 | US5741510 Transdermal delivery |
| 04/21/1998 | US5741507 Ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating |
| 04/21/1998 | US5741505 Edible products having inorganic coatings |
| 04/21/1998 | US5741500 Oral appliance |
| 04/21/1998 | US5741495 Glucan drug delivery system and adjuvant |
| 04/21/1998 | US5741485 Crystalline complexes has monoclinic morphology and x-ray diffraction |
| 04/21/1998 | US5741478 Preparation of hollow microcapsules by spray-drying an aqueous solution of a wall-forming material and a water-miscible solvent |
| 04/21/1998 | US5741330 Close vascularization implant material |
| 04/21/1998 | US5741243 Method of altering composition of nutritional product during enteral tube feeding |
| 04/21/1998 | US5740793 Dry powder inhalation device with elongate carrier for power |
| 04/21/1998 | CA2147626C Cell encapsulating device |
| 04/21/1998 | CA2089430C Aqueous pharmaceutical suspension for pharmaceutical active |
| 04/21/1998 | CA2064687C Method and device for administering dexmedetomidine transdermaly |